Iradimed (NASDAQ:IRMD) Updates FY 2024 Earnings Guidance

Iradimed (NASDAQ:IRMD – Get Free Report) updated its FY 2024 earnings guidance on Thursday. The company provided earnings per share guidance of 1.640-1.670 for the period, compared to the consensus earnings per share estimate of 1.560. The company issued revenue guidance of $72.7 million-$73.1 million, compared to the consensus revenue estimate of $72.6 million. Iradimed […]

Leave a Reply

Your email address will not be published.

Previous post Patriots veteran gives Drake Maye ultimate compliment after loss to Titans
Next post Maiar DEX Price Hits $0.0000 on Major Exchanges (MEX)